An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events

Trial Profile

An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Aspirin
  • Indications Cardiovascular disorders; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms INTREPID
  • Most Recent Events

    • 07 Jul 2016 Status changed from recruiting to discontinued as enrollment expectations were not met.
    • 24 Jul 2015 Planned End Date changed from 1 Nov 2017 to 1 Jan 2018 as per ClinicalTrials.gov record.
    • 24 Jul 2015 Planned primary completion date changed from 1 Oct 2017 to 1 Jan 2018 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top